BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11213898)

  • 1. Proposed guidelines on screening for risk of type 1 diabetes.
    Bingley PJ; Bonifacio E; Ziegler AG; Schatz DA; Atkinson MA; Eisenbarth GS;
    Diabetes Care; 2001 Feb; 24(2):398. PubMed ID: 11213898
    [No Abstract]   [Full Text] [Related]  

  • 2. Islet autoantibodies and their use in predicting insulin-dependent diabetes.
    Bonifacio E; Bingley PJ
    Acta Diabetol; 1997 Oct; 34(3):185-93. PubMed ID: 9401639
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined antibody screening for improved prediction of IDDM--modern strategies.
    Roll U; Ziegler AG
    Exp Clin Endocrinol Diabetes; 1997; 105(1):1-14. PubMed ID: 9088889
    [No Abstract]   [Full Text] [Related]  

  • 4. [Autoantibodies in type 1 diabetes mellitus].
    Ziegler M; Ziegler B
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):561-5. PubMed ID: 7856261
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunopathological and genetic features in slowly progressive insulin-dependent diabetes mellitus and latent autoimmune diabetes in adults.
    Kobayashi T; Tanaka S; Harii N; Aida K; Shimura H; Ohmori M; Kanesige M; Shimada A; Maruyama T
    Ann N Y Acad Sci; 2006 Oct; 1079():60-6. PubMed ID: 17130533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined analysis of autoantibodies against beta-cells for prediction of pancreas allograft failure.
    Da Silva M; Thivolet C; Lefrançois N; Bosshard S; Sepeteanu I; Petruzzo P; Dubernard JM; Martin X
    Transplant Proc; 2000 Dec; 32(8):2773. PubMed ID: 11134797
    [No Abstract]   [Full Text] [Related]  

  • 7. Islet autoimmunity in infants with a Type I diabetic relative is common but is frequently restricted to one autoantibody.
    Colman PG; Steele C; Couper JJ; Beresford SJ; Powell T; Kewming K; Pollard A; Gellert S; Tait B; Honeyman M; Harrison LC
    Diabetologia; 2000 Feb; 43(2):203-9. PubMed ID: 10753042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and immunological characteristics of Type I diabetes mellitus in an Indo-Aryan population.
    Kelly MA; Alvi NS; Croft NJ; Mijovic CH; Bottazzo GF; Barnett AH
    Diabetologia; 2000 Apr; 43(4):450-6. PubMed ID: 10819238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 1 diabetes islet autoantibody markers.
    Winter WE; Harris N; Schatz D
    Diabetes Technol Ther; 2002; 4(6):817-39. PubMed ID: 12614488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prediction and prevention of type I diabetes].
    Takino H; Yamaguchi Y; Nagataki S
    Nihon Rinsho; 1997 Nov; 55 Suppl():313-8. PubMed ID: 9434486
    [No Abstract]   [Full Text] [Related]  

  • 11. Beta-cell damage in diabetic insulitis: are we approaching a solution?
    Bottazzo GF
    Diabetologia; 1984 Apr; 26(4):241-9. PubMed ID: 6376230
    [No Abstract]   [Full Text] [Related]  

  • 12. Natural history and immunopathogenesis of type 1 diabetes.
    Pozzilli P; Strollo R; Barchetta I
    Endocrinol Nutr; 2009 Dec; 56 Suppl 4():50-2. PubMed ID: 20629233
    [No Abstract]   [Full Text] [Related]  

  • 13. Course of islet autoantibody titers during Ig-immunoadsorption in a patient with newly diagnosed type 1 diabetes.
    Seidel DK; Geiss HC; Donner MG; Ritter MM; Schwandt P; Koll RA; Standl E; Ziegler AG
    J Autoimmun; 1998 Jun; 11(3):273-7. PubMed ID: 9693976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selecting culprits in type 1 diabetes beta-cell killing.
    Lernmark A
    J Clin Invest; 1999 Dec; 104(11):1487-9. PubMed ID: 10587509
    [No Abstract]   [Full Text] [Related]  

  • 15. The Giessen-Bad Oeynhausen family study: improved prediction of type I diabetes in a low incidence population of relatives using combinations of islet autoantibodies in a dual step model.
    Jaeger C; Hatziagelaki E; Stroedter A; Becker F; Scherer S; Petzoldt R; Federlin K; Bretzel RG
    Exp Clin Endocrinol Diabetes; 1999; 107(8):496-505. PubMed ID: 10612480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to Bazzigaluppi et al.: capillary whole-blood measurement of islet autoantibodies.
    Costa A; Conget I; Casamitjana R
    Diabetes Care; 2000 Jun; 23(6):874. PubMed ID: 10841023
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus.
    Bingley PJ; Bonifacio E; Gale EA
    Lancet; 1994 Jul; 344(8917):266-7. PubMed ID: 7913179
    [No Abstract]   [Full Text] [Related]  

  • 18. Number of autoantibodies and HLA genotype, more than high titers of glutamic acid decarboxylase autoantibodies, predict insulin dependence in latent autoimmune diabetes of adults.
    Maioli M; Pes GM; Delitala G; Puddu L; Falorni A; Tolu F; Lampis R; Orrù V; Secchi G; Cicalò AM; Floris R; Madau GF; Pilosu RM; Whalen M; Cucca F
    Eur J Endocrinol; 2010 Oct; 163(4):541-9. PubMed ID: 20603341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence and predictive value of islet cell autoantibodies and anti-glutamic acid decarboxylase in a family study in Lyons].
    Thivolet C
    Journ Annu Diabetol Hotel Dieu; 1992; ():165-71. PubMed ID: 1495236
    [No Abstract]   [Full Text] [Related]  

  • 20. Glutamic acid decarboxylase antibodies in relation to other autoantibodies and genetic risk markers in children with newly diagnosed insulin-dependent diabetes. Childhood Diabetes in Finland Study Group.
    Sabbah E; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Tuomilehto-Wolf E; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2455-9. PubMed ID: 8675560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.